Alcista
$18.62
Precio del escenario
$57.750
-0.485 (-0.84%)Al cierre
Calumet, Inc. manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels to customers across a range of consumer-facing and industrial markets. Its segments include Specialty Products and Solutions, Montana/Renewables, and Performance Brands. The Specialty Products and Solutions segment consists of its customer-focused solutions and formulations businesses, covering multiple specialty product lines, anchored by its integrated complex in Northwest Louisiana. In this segment, it manufactures and markets a variety of solvents, waxes, customized lubricating oils, white oils, gels, esters, and other products. The Montana/Renewables segment is composed of its Montana Renewables facility and its Great Falls specialty asphalt facility. The Performance Brands segment includes its portfolio of high-performing brands. In this segment, it blends, packages, and markets high-performance products through its Royal Purple, Bel-Ray, and TruFuel brands.
Calumet Specialty Products Partners LP is a good buy right now due to its current price of $57.75, which is below the average analyst price target of $60 to $75. The stock has shown a strong year-to-date change of +195.40% and a one-year change of +207.51%, indicating robust growth. Additionally, the recent announcement of full EPA exemptions is expected to enhance financials by approximately $309 million, which significantly boosts investor confidence. However, a risk to consider is the forward P/E ratio of 49.02, indicating that the stock may be overvalued if growth does not meet expectations.
H.C. Wainwright
$75
2026-09-02
H.C. Wainwright
2026-09-02
Precio objetivo
$75
BofA
$60
2026-09-01
BofA
2026-09-01
Precio objetivo
$60
UBS
$47
2026-08-25
UBS
2026-08-25
Precio objetivo
$47
TD Cowen
$40
2026-08-12
TD Cowen
2026-08-12
Precio objetivo
$40
BofA
$45
2026-08-10
BofA
2026-08-10
Precio objetivo
$45
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

Calumet Announces Redemption of $150 Million Debt

Calumet to Report Q3 2026 Results on November 6

Calumet to Report Q3 2026 Results on November 6

Calumet Increases Loan Facility to $600 Million

Calumet Increases Asset-Based Loan Facility to $600 Million
Calumet, Inc. manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels to customers across a range of consumer-facing and industrial markets. Its segments include Specialty Products and Solutions, Montana/Renewables, and Performance Brands. The Specialty Products and Solutions segment consists of its customer-focused solutions and formulations businesses, covering multiple specialty product lines, anchored by its integrated complex in Northwest Louisiana. In this segment, it manufactures and markets a variety of solvents, waxes, customized lubricating oils, white oils, gels, esters, and other products. The Montana/Renewables segment is composed of its Montana Renewables facility and its Great Falls specialty asphalt facility. The Performance Brands segment includes its portfolio of high-performing brands. In this segment, it blends, packages, and markets high-performance products through its Royal Purple, Bel-Ray, and TruFuel brands. It operates in the Energy sector (PETROLEUM REFINING industry).
Calumet Specialty Products Partners LP is a good buy right now due to its current price of $57.75, which is below the average analyst price target of $60 to $75. The stock has shown a strong year-to-date change of +195.40% and a one-year change of +207.51%, indicating robust growth. Additionally, the recent announcement of full EPA exemptions is expected to enhance financials by approximately $309 million, which significantly boosts investor confidence. However, a risk to consider is the forward P/E ratio of 49.02, indicating that the stock may be overvalued if growth does not meet expectations.
5 analysts cover CLMT: 1 rate it Buy, 3 Hold and 1 Sell. The average price target is 23.67.

Wall St is expecting 1.55 EPS for $CLMT Q3 [Reporting 11/06 BMO]
Mostrar másEsta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.